J 2021

European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer

VAN KALSBEEK, R. J ., H. J. H. VAN DER PAL, L. C. M. KREMER, E. BARDI, M. C. BROWN et. al.

Základní údaje

Originální název

European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer

Autoři

VAN KALSBEEK, R. J . (garant), H. J. H. VAN DER PAL, L. C. M. KREMER, E. BARDI, M. C. BROWN, R. EFFENEY, J. F. WINTHER, C. FOLLIN, J. DEN HARTOGH, R. HAUPT, L. HJORTH, Tomáš KEPÁK (203 Česká republika, domácí), Kateřina KEPÁKOVÁ (203 Česká republika, domácí), G. LEVITT, J. J. LOONEN, M. MANGELSCHOTS, M. MURACA, M. RENARD, H. SABIC, C. U. SCHNEIDER, A. UYTTEBROECK, R. SKINNER a R. L. MULDER

Vydání

European Journal of Cancer, Oxford, Elsevier Science Inc. 2021, 0959-8049

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30204 Oncology

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 10.002

Kód RIV

RIV/00216224:14110/21:00124150

Organizační jednotka

Lékařská fakulta

UT WoS

000686049700036

Klíčová slova anglicky

Neoplasms; Cancer survivors; Survivorship; Aftercare; Practice guideline; Patient participation; Quality of life

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 15. 2. 2022 08:31, Mgr. Tereza Miškechová

Anotace

V originále

Background: Long-term follow-up (LTFU) care for childhood, adolescent, and young adult (CAYA) cancer survivors is essential to preserve health and quality of life (QoL). Evidence-based guidelines are needed to inform optimal surveillance strategies, but many topics are yet to be addressed by the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG). Therefore, the PanCareFollowUp Recommendations Working Group collaborated with stakeholders to develop European harmonised recommendations in anticipation of evidence-based IGHG guidelines. Methods: The PanCareFollowUp Recommendations Working Group, consisting of 23 late effects specialists, researchers, and survivor representatives from nine countries, collaborated in the first Europe-wide effort to provide unified recommendations in anticipation of evidence based guidelines. A pragmatic methodology was used to define recommendations for topics where no evidence-based IGHG recommendations exist. The objective was to describe the surveillance requirements for high-quality care while balancing the different infrastructures and resources across European health care systems. The process included two face-to-face meetings and an external consultation round involving 18 experts from 14 countries. Results: Twenty-five harmonised recommendations for LTFU care were developed collaboratively and address topics requiring awareness only (n = 6), awareness, history and/or physical examination (n = 9), or additional surveillance tests (n = 10). Conclusions: The PanCareFollowUp Recommendations, representing a unique agreement across European stakeholders, emphasise awareness among survivors and health care providers in addition to tailored clinical evaluation and/or surveillance tests. They include existing IGHG guidelines and additional recommendations developed by a pragmatic methodology and will be used in the Horizon 2020-funded PanCareFollowUp project to improve health and QoL of CAYA cancer survivors. (C) 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).